These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9562523)

  • 1. Molecular background of the Finnish disease heritage.
    Peltonen L
    Ann Med; 1997 Dec; 29(6):553-6. PubMed ID: 9562523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of the Finnish disease heritage.
    Peltonen L; Jalanko A; Varilo T
    Hum Mol Genet; 1999; 8(10):1913-23. PubMed ID: 10469845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Messages from an isolate: lessons from the Finnish gene pool.
    Peltonen L; Pekkarinen P; Aaltonen J
    Biol Chem Hoppe Seyler; 1995 Dec; 376(12):697-704. PubMed ID: 9072044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland.
    Kallinen J; Heinonen S; Palotie A; Mannermaa A; Ryynanen M
    Prenat Diagn; 2001 May; 21(5):409-12. PubMed ID: 11360285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Finnish disease heritage].
    Kestilä M; Ikonen E; Lehesjoki AE
    Duodecim; 2010; 126(19):2311-20. PubMed ID: 21086689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E; Peltonen L
    Hum Mutat; 1992; 1(5):361-5. PubMed ID: 1301945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive nature of aspartylglucosaminuria.
    Arvio P; Arvio M
    Acta Paediatr; 2002; 91(3):255-7. PubMed ID: 12022293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Anders Annual Prize for young researchers 1992. Identification of genes in human diseases].
    Palotie LP
    Nord Med; 1993; 108(2):40-1. PubMed ID: 8433944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.
    Syvänen AC; Ikonen E; Manninen T; Bengtström M; Söderlund H; Aula P; Peltonen L
    Genomics; 1992 Mar; 12(3):590-5. PubMed ID: 1559710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.
    Isoniemi A; Hietala M; Aula P; Jalanko A; Peltonen L
    Hum Mutat; 1995; 5(4):318-26. PubMed ID: 7627186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of carrier screening of aspartylglucosaminuria in Finland.
    Hietala M; Grön K; Syvänen AC; Peltonen L; Aula P
    Eur J Hum Genet; 1993; 1(4):296-300. PubMed ID: 8081942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positional cloning of the CLN5 gene defective in the Finnish variant of the LINCL.
    Klockars T; Savukoski M; Isosomppi J; Peltonen L
    Mol Genet Metab; 1999 Apr; 66(4):324-8. PubMed ID: 10191122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
    Saarela J; von Schantz C; Peltonen L; Jalanko A
    Hum Mutat; 2004 Oct; 24(4):350-1. PubMed ID: 15365992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Database for the mutations of the Finnish disease heritage.
    Sipilä K; Aula P
    Hum Mutat; 2002 Jan; 19(1):16-22. PubMed ID: 11754099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartylglucosaminuria in northern Norway: a molecular and genealogical study.
    Tollersrud OK; Nilssen O; Tranebjaerg L; Borud O
    J Med Genet; 1994 May; 31(5):360-3. PubMed ID: 8064811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of Finnish mutations causing aspartylglucosaminuria.
    Valkonen S; Hietala M; Savontaus ML; Aula P
    Hereditas; 1999; 131(3):191-5. PubMed ID: 10783529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single founder mutation (W380G) in type II protein C deficiency in Finland.
    Levo A; Kuismanen K; Holopainen P; Vahtera E; Rasi V; Holopainen P; Rasi V; Krusius T; Partanen J
    Thromb Haemost; 2000 Sep; 84(3):424-8. PubMed ID: 11019966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase.
    Mononen I; Heisterkamp N; Kaartinen V; Williams JC; Yates JR; Griffin PR; Hood LE; Groffen J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2941-5. PubMed ID: 2011603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartylglucosaminuria among Palestinian Arabs.
    Zlotogora J; Ben-Neriah Z; Abu-Libdeh BY; Sury V; Zeigler M
    J Inherit Metab Dis; 1997 Nov; 20(6):799-802. PubMed ID: 9427148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Finnish disease heritage: a personal look.
    Perheentupa J
    Acta Paediatr; 1995 Oct; 84(10):1094-9. PubMed ID: 8563216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.